---
document_datetime: 2023-09-21 17:46:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vargatef-epar-all-authorised-presentations_en.pdf
document_name: vargatef-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8773664
conversion_datetime: 2025-12-27 13:22:54.869097
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMA Number      | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                         |
|-----------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-----------------------------------|
| EU/1/14/954/001 | Vargatef          | 100 mg     | Capsule, soft         | Oral use                  | Blister (Alu/Alu)     | 60 capsules                       |
| EU/1/14/954/002 | Vargatef          | 100 mg     | Capsule, soft         | Oral use                  | Blister (Alu/Alu)     | 120 capsules                      |
| EU/1/14/954/003 | Vargatef          | 100 mg     | Capsule, soft         | Oral use                  | Blister (Alu/Alu)     | 120 (60 x 2) capsules (multipack) |
| EU/1/14/954/004 | Vargatef          | 150 mg     | Capsule, soft         | Oral use                  | Blister (Alu/Alu)     | 60 capsules                       |